Pacific Biosciences Of California (PACB) EV to FCF (2010 - 2026)

Pacific Biosciences Of California has reported EV to FCF for 17 years, with the latest figure at 7.68 in Q2 2026.

• On a quarterly basis, EV to FCF fell 298.44% year-over-year to 7.68 in Q2 2026; TTM through Jun 2026 was 2.31, a 510.18% decrease from a year earlier, with the FY2025 full-year figure at 2.5, down 256.9% from the prior year.
• EV to FCF was 7.68 for Q2 2026 at Pacific Biosciences Of California, down from 2.8 in the prior quarter.
• The five-year high for EV to FCF was 2.45 in Q2 2024, with the low at 56.84 in Q2 2023.
• Average EV to FCF over 5 years is 11.64, with a median of 6.43 recorded in 2024.
• The sharpest annual moves came in 2024 and 2025: EV to FCF jumped 104.31% in 2024, then sank 3813.96% in 2025.
• Over 5 years, EV to FCF stood at 16.5 in 2022, then plunged by 102.89% to 33.48 in 2023, then soared by 86.22% to 4.61 in 2024, then tumbled by 210.15% to 14.31 in 2025, then soared by 46.31% to 7.68 in 2026.
• The last three EV to FCF figures came in at 7.68 (Q2 2026), 2.8 (Q1 2026), and 14.31 (Q4 2025), per Business Quant data.